文献速递肿瘤 PET/CT

68Ga-PSMA-11 PET/CT注射剂量能否降低而保持病灶检出图像质量?

Can the Injected Dose Be Reduced in 68Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection?
PubMed 文献 · J Nucl Med · 2019-07-19

本研究对11例前列腺癌患者行68Ga-PSMA-11 PET/CT列表模式采集,分别重建3分钟(标准剂量)、2分钟(低剂量)和1分钟(极低剂量)图像,评估整体图像质量和PSMA阳性病灶检出率。结果显示图像质量随剂量降低而下降,病灶检出率亦随之降低,结论认为减少68Ga-PSMA-11剂量不可行。

要点

  • 标准剂量图像质量平均评分4.1±0.4,低剂量3.4±0.7,极低剂量1.9±0.4,差异均有统计学意义(P<0.05)。
  • 三名读者对21个病灶的检出率在标准剂量下为100%、100%、95%,低剂量下为95%、81%、90%,极低剂量下为71%、76%、59%。
  • 减少68Ga-PSMA-11注射剂量会对图像质量和病灶检出能力产生负面影响,临床不可行。

核心结论

  • 68Ga-PSMA-11剂量降低不可行,会对图像质量和病灶检出能力产生负面影响。

研究设计与样本

  • 对11例前列腺癌患者行68Ga-PSMA-11 PET/CT列表模式采集,重建3分钟(标准剂量)、2分钟(低剂量)和1分钟(极低剂量)图像。
  • 由3名读者评估整体图像质量(5分制)和PSMA阳性病灶检出率,并与参考标准比较。

主要发现

  • 图像质量随剂量降低而下降:标准剂量平均评分4.1±0.4,低剂量3.4±0.7,极低剂量1.9±0.4,所有P<0.05。
  • 读者1、2、3对21个病灶的检出率在标准剂量下分别为100%、100%、95%,低剂量下分别为95%、81%、90%,极低剂量下分别为71%、76%、59%。

临床怎么用

  • 临床不应以减少68Ga-PSMA-11注射剂量的方式来维持或提高图像质量与病灶检出率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Our purpose was to define a clinically useful lower limit of injected dose for 68Ga-prostate-specific membrane antigen (PSMA)-11 PET/CT imaging of prostate cancer. Methods:68Ga-PSMA-11 PET/CT was performed on 11 patients. PET was acquired in list mode and reconstructed using a 3-min full acquisition, a 2-min acquisition, and a 1-min acquisition to generate images obtained with three thirds (standard dose), two thirds (low dose), and one third (very low dose) of the injected dose, respectively. Overall image quality (5-point scale) was assessed, and the detectability of PSMA-positive lesions was determined by 3 readers and compared with the reference standard. Results: Image quality declined with decreasing dose (mean score of 4.1 ± 0.4 for the standard dose, 3.4 ± 0.7 for the low dose, and 1.9 ± 0.4 for the very low dose; all P < 0.05). Readers 1, 2, and 3 correctly identified the lesions (n = 21) at a rate of 100%, 100%, and 95% with the standard dose; 95%, 81%, and 90% with the low dose; and 71%, 76%, and 59% with the very low dose, respectively. Conclusion:68Ga-PSMA-11 dose reduction is not feasible without a negative impact on image quality and lesion detectability.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Rauscher I, Fendler WP, Hope TA, et al. Can the Injected Dose Be Reduced in 68Ga-PSMA-11 PET/CT While Maintaining High Image Quality for Lesion Detection? J Nucl Med. 2019. PMID: 31324710. doi:10.2967/jnumed.119.227207

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。